These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23454051)

  • 41. Analytical, biopharmaceutical and regulatory evaluation of topical testosterone preparations.
    Baert B; Annavarapu S; Burvenich C; De Spiegeleer B
    Eur J Pharm Biopharm; 2009 May; 72(1):275-81. PubMed ID: 19026745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relevant shaking stress conditions for antibody preformulation development.
    Eppler A; Weigandt M; Hanefeld A; Bunjes H
    Eur J Pharm Biopharm; 2010 Feb; 74(2):139-47. PubMed ID: 19922795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Issues and challenges of subvisible and submicron particulate analysis in protein solutions.
    Scherer TM; Leung S; Owyang L; Shire SJ
    AAPS J; 2012 Jun; 14(2):236-43. PubMed ID: 22391789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visible particle limits in small volume parenterals.
    Leelarasamee N; Howard SA; Baldwin HJ
    J Parenter Drug Assoc; 1980; 34(3):167-74. PubMed ID: 6901772
    [No Abstract]   [Full Text] [Related]  

  • 45. Shaken, not stirred: mechanical stress testing of an IgG1 antibody.
    Kiese S; Papppenberger A; Friess W; Mahler HC
    J Pharm Sci; 2008 Oct; 97(10):4347-66. PubMed ID: 18240293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How subvisible particles become invisible-relevance of the refractive index for protein particle analysis.
    Zölls S; Gregoritza M; Tantipolphan R; Wiggenhorn M; Winter G; Friess W; Hawe A
    J Pharm Sci; 2013 May; 102(5):1434-46. PubMed ID: 23463514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals.
    Bernuzzi M; Raggi P; Montanari L; Pregnolato F; Pavanetto F
    J Parenter Sci Technol; 1993; 47(5):265-9. PubMed ID: 8263664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulin.
    Gross S; Janssen SW; de Vries B; Terao E; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):11-25. PubMed ID: 20144449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.
    Zhou C; Krueger AB; Barnard JG; Qi W; Carpenter JF
    J Pharm Sci; 2015 Aug; 104(8):2441-50. PubMed ID: 26017684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calorimetric study of bovine serum albumin dilution and adsorption onto polystyrene particles.
    Pollitt MJ; Buckton G; Brocchini S; Alpar HO
    Int J Pharm; 2005 Jul; 298(2):333-8. PubMed ID: 15878810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiwavelength transmission spectroscopy revisited for the characterization of the protein and polystyrene nanoparticle mixtures.
    Serebrennikova YM; Roth A; Huffman DE; Smith JM; Lindon JN; García-Rubio LH
    Appl Spectrosc; 2013 Feb; 67(2):196-203. PubMed ID: 23622439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant.
    Frahm GE; Pochopsky AW; Clarke TM; Johnston MJ
    PLoS One; 2016; 11(2):e0150229. PubMed ID: 26925777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of agitation on size distribution of particulate matter in large-volume parenterals.
    Blanchard J; Schwartz JA; Byrne DM
    J Pharm Sci; 1977 Jul; 66(7):935-8. PubMed ID: 886454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple method for the detection of insoluble aggregates in protein formulations.
    Li B; Flores J; Corvari V
    J Pharm Sci; 2007 Jul; 96(7):1840-3. PubMed ID: 17299781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Raman microscopic applications in the biopharmaceutical industry: in situ identification of foreign particulates inside glass containers with aqueous formulated solutions.
    Cao X; Wen ZQ; Vance A; Torraca G
    Appl Spectrosc; 2009 Jul; 63(7):830-4. PubMed ID: 19589222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of two methods for obtaining size distribution characteristics of particulate matter in large-volume parenterals.
    Blanchard J; Schwartz JA; Byrne DM; Marx DB
    J Pharm Sci; 1978 Mar; 67(3):340-4. PubMed ID: 641718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.